News

Published on 27 Feb 2024 on Simply Wall St. via Yahoo Finance

Institutional investors own a significant stake of 41% in Poseida Therapeutics, Inc. (NASDAQ:PSTX)


Article preview image

Key Insights

Institutions' substantial holdings in Poseida Therapeutics implies that they have significant influence over the company's share price55% of the business is held by the top 6 shareholders Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business

To get a sense of who is truly in control of Poseida Therapeutics, Inc. (NASDAQ:PSTX), it is important to understand the ownership structure of the business. With 41% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

NASDAQ.PSTX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
US$14.00 - That's What Analysts Think Poseida Therapeutics, Inc. (NASDAQ:PSTX) Is Worth After These...

Poseida Therapeutics, Inc. (NASDAQ:PSTX) just released its latest full-year results and things ar...

Simply Wall St. via Yahoo Finance 10 Mar 2024

Poseida Therapeutics, Inc. (PSTX) Reports Q4 Loss, Tops Revenue Estimates

Poseida Therapeutics, Inc. (PSTX) came out with a quarterly loss of $0.27 per share versus the Za...

Zacks via Yahoo Finance 8 Mar 2024

Institutional investors own a significant stake of 41% in Poseida Therapeutics, Inc. (NASDAQ:PSTX)

Key Insights Institutions' substantial holdings in Poseida Therapeutics implies that they have si...

Simply Wall St. via Yahoo Finance 27 Feb 2024

Poseida Therapeutics, Inc. (PSTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects Poseida Therapeutics, Inc. (PSTX) to deliver a year-over-year decline in earni...

Zacks via Yahoo Finance 2 Nov 2023

All You Need to Know About Poseida Therapeutics, Inc. (PSTX) Rating Upgrade to Buy

Investors might want to bet on Poseida Therapeutics, Inc. (PSTX), as it has been recently upgrade...

Zacks via Yahoo Finance 16 Oct 2023

Institutional investors may adopt severe steps after Poseida Therapeutics, Inc.'s (NASDAQ:PSTX)...

Key Insights Significantly high institutional ownership implies Poseida Therapeutics' stock price...

Simply Wall St. via Yahoo Finance 20 Sep 2023

News Flash: Analysts Just Made An Upgrade To Their Poseida Therapeutics, Inc. (NASDAQ:PSTX)...

Poseida Therapeutics, Inc. (NASDAQ:PSTX) shareholders will have a reason to smile today, with the...

Simply Wall St. via Yahoo Finance 10 Aug 2023

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's...

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's...

Investing.com 9 Aug 2023

Poseida Therapeutics, Inc. (PSTX) Reports Q2 Loss, Tops Revenue Estimates

Poseida Therapeutics, Inc. (PSTX) came out with a quarterly loss of $0.32 per share versus the Za...

Zacks via Yahoo Finance 9 Aug 2023

The past three years for Poseida Therapeutics (NASDAQ:PSTX) investors has not been profitable

It's not possible to invest over long periods without making some bad investments. But you want t...

Simply Wall St. via Yahoo Finance 31 Jul 2023